ArcScan, Inc announced that it has entered into stock purchase agreement with new investor Shanghai Haohai Biological Technology Co., Ltd for private placement of preferred shares for gross proceeds of $11.15 million on July 21, 2021.
Shanghai Haohai Biological Technology Co., Ltd.
Equities
6826
CNE100001W69
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
42.45 HKD | -0.35% | +3.79% | +5.33% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+5.33% | 2.01B | |
-4.02% | 184B | |
-0.75% | 109B | |
-2.97% | 68.37B | |
+4.48% | 51.56B | |
+9.09% | 44.69B | |
+4.37% | 41.49B | |
+3.12% | 26.75B | |
+4.10% | 26.7B | |
+15.38% | 25.68B |
- Stock Market
- Equities
- 6826 Stock
- News Shanghai Haohai Biological Technology Co., Ltd.
- ArcScan, Inc. announced that it expects to receive $11.15 million in funding from Shanghai Haohai Biological Technology Co., Ltd.